The Latest Breaking News from Gilgamesh

Private psychedelics biotech company Gilgamesh Pharmaceuticals is currently developing a diverse portfolio of novel, potentially first-in-class compounds targeting mechanisms with demonstrated clinical efficacy, onset duration or prolonged treatment duration, for the treatment of psychiatric conditions.

Throughout the last decade, more and more companies have popped up that are focused on discovering and developing psychedelic compounds to revolutionize the treatment of mental illness. A number of these companies, including Atai Life Sciences (NASDAQ:ATAI) and Compass Pathways (NASDAQ:CMPS) are already publicly traded.  But today we will take a…